Optimising dose-dense regimens for early breast cancer | Cancer World Archive
Current status of dose-dense chemotherapy for breast cancer | SpringerLink
ESMO 2022: Dose-dense adjuvant chemotherapy in early-stage breast cancer patients: End-of-study results from a randomised, phase III trial of the Gruppo Italiano Mammella (GIM)
Comparative hematological profiles for dose‑dense vs. regular anthracycline‑based neoadjuvant chemotherapy in non‑metastatic breast cancer
Survival benefit of pure dose-dense chemotherapy in breast cancer: a meta-analysis of randomized controlled trials | World Journal of Surgical Oncology | Full Text
Dose-Dense Adjuvant Chemotherapy “Optimal” for High-Risk Early Breast Cancer - Cancer Therapy Advisor
Dose Dense-Intensive Chemotherapy Improves Survival in Early Stage Breast Cancer - CancerConnect
Survival outcomes for dose‐dense paclitaxel plus carboplatin neoadjuvant vs standard adjuvant chemotherapy in stage II to III triple‐negative breast cancer: A prospective cohort study with propensity‐matched analysis - Xiu - 2022 -
Optimising dose-dense regimens for early breast cancer | Cancer World Archive
Comparative hematological profiles for dose‑dense vs. regular anthracycline‑based neoadjuvant chemotherapy in non‑metastatic breast cancer
乳癌 dose-dense PTX療法 - 横須賀共済病院
Dose-dense paclitaxel plus carboplatin <i>vs</i>. epirubicin and cyclophosphamide with paclitaxel as adjuvant chemotherapy for high-risk triple-negative breast cancer
Phase III randomised trial comparing intense dose-dense chemotherapy to tailored dose-dense chemotherapy in high-risk early breast cancer (GAIN-2) - ScienceDirect
Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study | British Journal of Cancer
Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin as the Gold Standard Neoadjuvant Chemotherapy Regimen for Patients With Nonmetastatic Muscle-Invasive Bladder Cancer Remains Controversial | Journal of Clinical Oncology
Dose-dense chemotherapy in breast cancer and lymphoma - ScienceDirect
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials - The Lancet
Dose-dense chemotherapy for breast cancer: what does the future hold? | Future Oncology
外科 - dose - dense - EC - 乳腺 - q2w
Myeloid Growth Factor Support for Dose-Dense Adjuvant Chemotherapy for Breast Cancer
Real world experience with dose dense ac-paclitaxel: Two canadian cancer centers' experience | Semantic Scholar
Trial design of AGO trial, intense dose-dense epirubicin, paclitaxel,... | Download Scientific Diagram
Does dose-dense neoadjuvant chemotherapy have clinically significant prognostic value in breast cancer?: A meta-analysis of 3,724 patients | PLOS ONE
Dose intense, dose dense and tailored dose adjuvant chemotherapy for early breast cancer: an evolution of concepts
Dose-dense therapy is of benefit in primary treatment of ovarian cancer? In favor - ScienceDirect
Optimising dose-dense regimens for early breast cancer | Cancer World Archive
